Strathcona Announces Q1 2024 Conference Call
Get Alerts SCR Hot Sheet
Join SI Premium – FREE
Date: | |
Time: | |
URL Entry: | To join without operator assistance, register here up to 15 minutes before the start time. Enter your name and phone number to receive an automated call-back. |
Telephone Entry: | Alternatively, you can join with operator assistance by dialing 1 (888) 390-0605 (North American Toll Free) and quote conference ID 965818. |
Webcast Link: |
For those unable to participate in the conference call at the scheduled time, a recording of the conference call will be available for seven days following the call and can be accessed by dialing 1 (888) 390-0541 and entering the conference number 965818.
For those unable to participate in the conference call at the scheduled time, a recording of the conference call will be available for seven days following the call and can be accessed by dialing 1 (888) 390-0541 and entering the conference number 836882.
Strathcona Resources is one of
For more information about Strathcona Resources, visit www.strathconaresources.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/strathcona-announces-q1-2024-conference-call-302117264.html
SOURCE Strathcona Resources Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
- PSQL INVESTIGATION: Pasqal Holding Investors Should Contact Block & Leviton to Possibly Recover Losses
- Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share